EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The diagnostic value of the central vein sign in radiologically isolated syndrome

Cassandre Landes-Chateau iD, Michael Levraut iD, Darin T Okuda iD, Albert Themelin, Mikael Cohen iD, Orhun H Kantarci iD, Aksel Siva iD, Daniel Pelletier, Lydiane Mondot iD, Christine Lebrun-Frenay iD, on behalf RISConsortium

Annals of Clinical and Translational Neurology · 2024-03 · 11 (3) · 662-672

DOI: 10.1002/acn3.51986 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 08.01.2024. Verfasst von Cassandre Landes-Chateau und 10 weiteren Autor:innen. Beteiligte Einrichtung: Université Cote d'Azur, UMR2CA (URRIS), Nice, France. Hauptthemen laut MEDLINE: Demyelinating Diseases, Multiple Sclerosis. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The radiologically isolated syndrome (RIS) represents the earliest detectable preclinical phase of multiple sclerosis (MS). Increasing evidence suggests that the central vein sign (CVS) enhances lesion specificity, allowing for greater MS diagnostic accuracy. This study evaluated the diagnostic performance of the CVS in RIS.

Methods

Patients were prospectively recruited in a single tertiary center for MS care. Participants with RIS were included and compared to a control group of sex and age‐matched subjects. All participants underwent 3 Tesla magnetic resonance imaging, including postcontrast susceptibility‐based sequences, and the presence of CVS was analyzed. Sensitivity and specificity were assessed for different CVS lesion criteria, defined by proportions of lesions positive for CVS (CVS+) or by the absolute number of CVS+ lesions.

Results

180 participants (45 RIS, 45 MS, 90 non‐MS) were included, representing 5285 white matter lesions. Among them, 4608 were eligible for the CVS assessment (970 in RIS, 1378 in MS, and 2260 in non‐MS). According to independent ROC comparisons, the proportion of CVS+ lesions performed similarly in diagnosing RIS from non‐MS than MS from non‐MS ( p = 0.837). When a 6‐lesion CVS+ threshold was applied, RIS lesions could be diagnosed with an accuracy of 87%. MS could be diagnosed with a sensitivity of 98% and a specificity of 83%. Adding OCBs or Kappa index to CVS biomarker increased the specificity to 100% for RIS diagnosis.

Interpretation

This study shows evidence that CVS is an effective imaging biomarker in differentiating RIS from non‐MS, with similar performances to those in MS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Demyelinating DiseasesMultiple SclerosisHumansMagnetic Resonance ImagingSensitivity and SpecificityBiomarkers

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Université Cote d'Azur, UMR2CA (URRIS), Nice, France.
  • Service de Médecine Interne, Centre Hospitalier Universitaire de Nice, Hôpital l'Archet 1, Nice, France.
  • The University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Service de Radiologie, Centre Hospitalier Universitaire de Nice, Hôpital Pasteur 2, Nice, France.
  • Service de Neurologie, Centre de Ressource et de Compétence Sclérose en Plaques (CRC-SEP), Centre Hospitalier Universitaire de Nice, Hôpital Pasteur 2, Nice, France.
  • Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: Cassandre Landes-Chateau, Michael Levraut, Darin T Okuda, Mikael Cohen, Orhun H Kantarci, Aksel Siva, Lydiane Mondot, Christine Lebrun-Frenay

Förderung

  • NINDS NIH HHS

Zitieren

APA

Landes-Chateau, C., Levraut, M., Okuda, D. T., Themelin, A., Cohen, M., Kantarci, O. H., Siva, A., Pelletier, D., Mondot, L., Lebrun-Frenay, C., & on behalf RISConsortium (2024). The diagnostic value of the central vein sign in radiologically isolated syndrome. Annals of Clinical and Translational Neurology, 11(3), 662-672. https://doi.org/10.1002/acn3.51986

Vancouver

Landes-Chateau C, Levraut M, Okuda DT, Themelin A, Cohen M, Kantarci OH, et al. The diagnostic value of the central vein sign in radiologically isolated syndrome. Annals of Clinical and Translational Neurology. 2024;11(3):662-672. doi:10.1002/acn3.51986

BibTeX
@article{LandesChateau2024,
  author = {Landes-Chateau, Cassandre and Levraut, Michael and Okuda, Darin T and Themelin, Albert and Cohen, Mikael and Kantarci, Orhun H and Siva, Aksel and Pelletier, Daniel and Mondot, Lydiane and Lebrun-Frenay, Christine and on behalf RISConsortium, on behalf RISConsortium},
  title = {The diagnostic value of the central vein sign in radiologically isolated syndrome},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2024},
  volume = {11},
  number = {3},
  pages = {662--672},
  doi = {10.1002/acn3.51986}
}
Kostenlos starten →